Fig. 2
The impact of different treatment regimens on patient remission and relapse
Abbreviations: Blue P represents the remission difference between different treatment groups
P [1]: After correcting for hypertension, the differences between patient groups treated with or without a combination of GCs and/or IMS were compared; P [2]: After correcting for hemoglobin, CD20, UN, and PLA2R; time to use; glomerular arteriosclerosis; standard treatment; and RNS; the differences between the initial treatment and non-initial treatment patient groups were compared; P [3]: After correcting for RNS; time to use; and initial treatment. compared the differences between the standard treatment and non-standard treatment patient groups
Yellow P represents the difference in relapse between the different treatment groups
Pa: After hypertension was corrected, the differences between patient groups treated with or without a combination of GCs and/or the IMS were compared. Pb: After the hemoglobin, UN, PLA2R, time to use, standard treatment, and RNS were corrected, the differences between the initial treatment and non-initia treatment patient groups were compared. Pc: After UN, RNS, the time to use, and initial treatment were corrected. compared the differences between the standard treatment and non-standard treatment patient groups
GCs, glucocorticoid; IMS, immunosuppressant; UN, urea nitrogen; PLA2R, phospholipase A2 receptor; RNS, refractory nephrotic syndrome